Teva Pharmaceutical Industries Ltd. (TEVA)
Market Closed
10 Aug, 15:25
TASE TASE Primary 
OTC PINK 10,650. 00
ILA +150
+1.4286%
20.84B Market Cap
- P/E Ratio
0.34% Div Yield
920,617 Volume
- Eps
10,500 ILA
Previous Close Want to track TEVA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Teva Pharmaceutical Industries Ltd. (TEVA) Statistics
Valuation metrics
Market Cap 20.84B
Enterprise value 53.88B
Trailing P/E (ttm) 54.68
Forward P/E -
PEG ratio 0.1
Price/Sales (ttm) 2.34
Price/Book (mrq) 5.26
Enterprise Value/Revenue 3.1
Enterprise Value/EBITDA 17.48
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 277.59K
Average volume (90 days) 922.7K
Price summary
52-Week low 5,572
52-Week high 11,350
Beta -
50-Day moving average 10,075.75
200-Day moving average 9,972.72
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 2:1
Last split Date 27 Jun 2004
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.04%
Operating margin 0.17%
Operational effectiveness
Return on assets 0.02%
Return on equity 0.09%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 14.94
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.62
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.12
Total debt (mrq) -
Total Debt/Equity (mrq) 2.16
Current ratio (mrq) 0.88%
Book value per share (mrq) 6.66
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
